BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38708583)

  • 21. Detecting human CD34+ and CD34- hematopoietic stem and progenitor cells using a Sysmex automated hematology analyzer.
    Wang FS; Rowan RM; Creer M; Hay A; Dorfner M; Peesapati S; Connell B; Nakamura Y; Inagaki A; Otani I; Hamaguchi Y; Hirai K
    Lab Hematol; 2004; 10(4):200-5. PubMed ID: 15697089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Semi-automated flow cytometric analysis of CD34-expressing hematopoietic cells in peripheral blood progenitor cell apheresis products.
    Gutensohn K; Carrero I; Krueger W; Kroeger N; Schäfer P; Luedemann K; Kuehnl P
    Transfusion; 1999; 39(11-12):1220-6. PubMed ID: 10604249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enumeration of CD34+ hematopoietic progenitor cells for clinical transplantation: comparison of three different methods.
    Venditti A; Battaglia A; Del Poeta G; Buccisano F; Maurillo L; Tamburini A; Del Moro B; Epiceno AM; Martiradonna M; Caravita T; Santinelli S; Adorno G; Picardi A; Zinno F; Lanti A; Bruno A; Suppo G; Franchi A; Franconi G; Amadori S
    Bone Marrow Transplant; 1999 Nov; 24(9):1019-27. PubMed ID: 10556963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hematopoietic progenitor cell count, but not immature platelet fraction value, predicts successful harvest of autologous peripheral blood stem cells.
    Mitani N; Yujiri T; Tanaka Y; Tanaka M; Fujii Y; Hinoda Y; Tanizawa Y
    J Clin Apher; 2011; 26(3):105-10. PubMed ID: 21647950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The new Sysmex XN-2000 automated blood cell analyzer more accurately measures the absolute number and the proportion of hematopoietic stem and progenitor cells than XE-2100 when compared to flow cytometric enumeration of CD34+ cells.
    Park SH; Park CJ; Kim MJ; Han MY; Han SH; Cho YU; Jang S
    Ann Lab Med; 2015 Jan; 35(1):146-8. PubMed ID: 25553297
    [No Abstract]   [Full Text] [Related]  

  • 26. Optimizing the CD34+ and CD34+Thy-1+ stem cell content of peripheral blood collections.
    Stewart AK; Imrie K; Keating A; Anania S; Nayar R; Sutherland DR
    Exp Hematol; 1995 Dec; 23(14):1619-27. PubMed ID: 8542956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enumeration of CD34+ hematopoietic stem and progenitor cells.
    Sutherland DR; Keeney M; Gratama JW
    Curr Protoc Cytom; 2003 Aug; Chapter 6():Unit 6.4. PubMed ID: 18770780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validation of a single-platform method for hematopoietic CD34+ stem cells enumeration according to accreditation procedure.
    Massin F; Huili C; Decot V; Stoltz JF; Bensoussan D; Latger-Cannard V
    Biomed Mater Eng; 2015; 25(1 Suppl):27-39. PubMed ID: 25538053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells. European Working Group on Clinical Cell Analysis.
    Gratama JW; Orfao A; Barnett D; Brando B; Huber A; Janossy G; Johnsen HE; Keeney M; Marti GE; Preijers F; Rothe G; Serke S; Sutherland DR; Van der Schoot CE; Schmitz G; Papa S
    Cytometry; 1998 Jun; 34(3):128-42. PubMed ID: 9696157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of volumetric capillary cytometry with standard flow cytometry for routine enumeration of CD34+ cells.
    Cabezudo E; Querol S; Cancelas JA; García J
    Transfusion; 1999 Aug; 39(8):864-72. PubMed ID: 10504123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical usefulness of the hematopoietic progenitor cell counts in predicting the optimal timing of peripheral blood stem cell harvest.
    Lee JL; Kim SB; Lee GW; Ryu MH; Kim EK; Kim S; Kim WK; Lee JS; Park KU; Suh C
    J Korean Med Sci; 2003 Feb; 18(1):27-35. PubMed ID: 12589083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of erythrocyte lysing procedures on the recovery of hematopoietic progenitor cells in flow cytometric analysis.
    Greve B; Beller C; Cassens U; Sibrowski W; Göhde W
    Stem Cells; 2006 Mar; 24(3):793-9. PubMed ID: 16210405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Highly specific functional equivalence of XN-HPC for optimum CD34+ cell count in harvested allogeneic bone marrow stem cell products.
    Jamal A; Khan T; Zaidi U; Rizvi QA; Jahanzeb S; Salim A; Imam M; Shamsi T
    Hematology; 2022 Dec; 27(1):232-238. PubMed ID: 35156559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hematopoietic Progenitor Cell Counts of the Leukapheresis Product Determined Using Sysmex XN Analyzers Predict a Sufficient Number of CD34
    Imoto N; Kondo Y; Uchida K; Kurahashi S
    Intern Med; 2024 Jan; 63(2):189-195. PubMed ID: 37225486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transplantation with selected autologous peripheral blood CD34+Thy1+ hematopoietic stem cells (HSCs) in multiple myeloma: impact of HSC dose on engraftment, safety, and immune reconstitution.
    Michallet M; Philip T; Philip I; Godinot H; Sebban C; Salles G; Thiebaut A; Biron P; Lopez F; Mazars P; Roubi N; Leemhuis T; Hanania E; Reading C; Fine G; Atkinson K; Juttner C; Coiffier B; Fière D; Archimbaud E
    Exp Hematol; 2000 Jul; 28(7):858-70. PubMed ID: 10907648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clearance time of infused hematopoietic stem cell from the blood circulation.
    Donmez A; Ozsan F; Arik B; Ozkayin N; Cagirgan S; Mir S; Vural F; Tombuloglu M
    Transfus Apher Sci; 2013 Apr; 48(2):235-9. PubMed ID: 23428427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mobilization kinetics of CD34+ hematopoietic stem cells stimulated by G-CSF and cyclophosphamide in patients with multiple sclerosis who receive an autotransplant.
    Jaime-Pérez JC; Gómez-Galaviz AC; Turrubiates-Hernández GA; Picón-Galindo E; Salazar-Riojas R; Méndez-Ramírez N; Gómez-Almaguer D
    Cytotherapy; 2020 Mar; 22(3):144-148. PubMed ID: 32057615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved Prediction of CD34+ Cell Yield before Peripheral Blood Hematopoietic Progenitor Cell Collection Using a Modified Target Value-Tailored Approach.
    Sheppard D; Tay J; Palmer D; Xenocostas A; Doulaverakis C; Huebsch L; McDiarmid S; Tinmouth A; Mallick R; Martin L; Birch P; Hamelin L; Allan D; Bredeson C
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):763-767. PubMed ID: 26643030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Hematopoietic Progenitor Cell Count as an Indicator for Optimal Timing of Peripheral Stem Cell Harvest in Clinical Practice.
    Tanaka H; Ishii A; Sugita Y; Shimizu R; Sato F; Sakuma Y; Iwai R; Kakuta S
    J Clin Exp Hematop; 2017; 56(3):150-159. PubMed ID: 28331129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single platform flow cytometric absolute CD34+ cell counts based on the ISHAGE guidelines. International Society of Hematotherapy and Graft Engineering.
    Keeney M; Chin-Yee I; Weir K; Popma J; Nayar R; Sutherland DR
    Cytometry; 1998 Apr; 34(2):61-70. PubMed ID: 9579602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.